Atrial Flutter Market: Demand Trends and Growth Outlook

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Atrial Flutter Market Expected To Scale Between 2026 And 2030?

The atrial flutter market has seen swift growth in recent years. It is projected to increase from $22.99 billion in 2025 to $26.52 billion in 2026, showing a compound annual growth rate (CAGR) of 15.4%. The expansion observed in the historic period is due to the increasing prevalence of cardiac arrhythmias, a rising aging population, the establishment of more cardiology specialty clinics, the adoption of ECG-based diagnostic tools, and the accessibility of pharmacological rhythm control therapies.

The atrial flutter market is anticipated to experience substantial growth over the next few years, with projections indicating it will reach $46.47 billion by 2030, driven by a compound annual growth rate (CAGR) of 15.0%. This expansion during the forecast period is attributed to several factors, including the increasing demand for minimally invasive cardiac procedures, the rising adoption of digital cardiac monitoring, the expansion of personalized arrhythmia treatment approaches, growing investments in electrophysiology technologies, and an increasing focus on stroke prevention strategies. Furthermore, significant trends expected in this period involve the increasing adoption of advanced cardiac mapping technologies, the rising use of catheter ablation procedures, the growing integration of wearable cardiac monitoring devices, the expansion of early diagnosis and screening programs, and an enhanced focus on minimally invasive treatments.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/atrial-flutter-global-market-report

Which Strong Drivers Are Impacting The Atrial Flutter Market Growth?

The anticipated expansion of the atrial flutter market is closely linked to the increasing occurrence of cardiovascular diseases. CVDs represent a broad spectrum of health conditions impacting the heart and blood vessels. This escalation in cardiovascular diseases is primarily attributable to an aging population, inactive lifestyles, inadequate nutrition, elevated obesity rates, and stress-related factors. As cardiovascular diseases become more prevalent, a greater number of individuals face a risk of atrial flutter, thereby stimulating increased demand for diagnostic tools and treatment solutions. For instance, according to the British Heart Foundation, a UK-based cardiovascular research charity, in September 2024, approximately 7.6 million individuals in the UK were affected by heart and circulatory diseases, consisting of 4 million men and 3.6 million women. It is projected that this number could increase by 1 million by 2030, and by 2040, it may rise to 2 million more than the current figures. Therefore, the growing incidence of cardiovascular diseases is a key driver for the growth of the atrial flutter market.

How Is The Atrial Flutter Market Broken Down By Segment Categories?

The atrial flutter market covered in this report is segmented –

1) By Type: Typical Atrial Flutter, Atypical Atrial Flutter, Left Atrial Flutter, Reverse Typical Atrial Flutter, Incisional Atrial Re-Entry

2) By Treatment: Antiarrhythmics, Beta-Blockers, Anticoagulants, Cardioversion, Catheter Ablation, Surgery, Other Treatments

3) By Diagnosis: Holter Monitoring, Blood Tests, Electrocardiography (ECG), Event Monitoring, Other Diagnosis

4) By Route Of Administration: Oral, Intravenous, Other Routes Of Administration

5) By End Users: Clinic, Hospital, Other End Users

Subsegments:

1) By Typical Atrial Flutter: Type I Atrial Flutter (Caval Tricuspid Isthmus Dependent), Type II Atrial Flutter (Right Atrial Macro-Reentry), Focal Typical Atrial Flutter, Post-Surgical Typical Atrial Flutter

2) By Atypical Atrial Flutter: Left Atrial Atypical Flutter, Right Atrial Atypical Flutter, Focal Atypical Flutter, Multifocal Atypical Flutter

3) By Left Atrial Flutter: Left Atrial Macro-Reentry Flutter, Left Atrial Focal Flutter, Left Atrial Flutter Post-Surgery

4) By Reverse Typical Atrial Flutter: Reverse Typical Flutter With Counterclockwise Rotation, Reverse Typical Flutter With Clockwise Rotation, Post-Cardiac Surgery Reverse Typical Flutter

5) By Incisional Atrial Re-Entry: Post-Surgical Atrial Flutter (Incisional Flutter), Incisional Re-Entry Flutter After Cardiac Procedures, Incisional Flutter Due To Atrial Scar Tissue

Which Trends Are Contributing To Changes In The Atrial Flutter Market?

Leading companies in the atrial flutter market are concentrating on integrating monitoring technologies, such as arrhythmia detection algorithms, to enhance diagnostic precision, improve treatment results, and optimize patient care. These specialized software tools analyze data from electrocardiograms (ECGs) or wearable heart monitors to pinpoint irregularities in heart rhythm and detect abnormal patterns indicative of arrhythmias, including atrial flutter. For instance, in May 2024, Vivalink, Inc., a US-based connected health technology company, introduced a turnkey ambulatory cardiac monitoring solution for mobile cardiac telemetry (MCT) and Holter monitoring, aiming to improve remote patient care. This solution employs cutting-edge software to continuously analyze data from electrocardiograms (ECGs) and wearable heart monitors, facilitating real-time identification of irregular heart rhythms such as atrial flutter. The solution features a reusable electrocardiogram (ECG) patch equipped with a 14-day rechargeable battery and up to 30 days of data storage. Furthermore, it includes a mobile gateway integrated with a patient app for seamless data transmission, an advanced algorithm capable of detecting over 15 arrhythmias, and a clinician portal for in-depth analysis and report customization.

Which Players Are Present In The Atrial Flutter Market Space?

Major companies operating in the atrial flutter market are Pfizer Inc., Johnson & Johnson, Siemens AG, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, Medtronic PLC, Boehringer Ingelheim GmbH, Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Astellas Pharma Inc., Zoll Medical Corporation, St. Jude Medical Inc., Biotronik SE & Co., iRhythm Technologies Inc., AtriCure Inc., Adagio Medical Inc., Acutus Medical Inc., Abbott Vascular

Get The Full Atrial Flutter Market Report:

https://www.thebusinessresearchcompany.com/report/atrial-flutter-global-market-report

Which Region Represents The Largest Share Of The Atrial Flutter Market?

North America was the largest region in the atrial flutter market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atrial flutter market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Atrial Flutter Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/atrial-flutter-global-market-report

Browse Through More Reports Similar to the Global Atrial Flutter Market 2026, By The Business Research Company

Wearable Heart Monitoring Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/wearable-heart-monitoring-devices-global-market-report

Implantable Heart Pacemaker Market Report 2026

https://www.thebusinessresearchcompany.com/report/implantable-heart-pacemaker-global-market-report

Heart Pump Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/heart-pump-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795